| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $438 to $495.
Goldman Sachs analyst Scott Fidel assumes HCA Healthcare (NYSE:HCA) with a Buy rating and announces Price Target of $470.
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $370 ...
Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from ...
Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $444 price target.
HCA Healthcare (NYSE: HCA) has outperformed the market over the past 5 years by 12.38% on an annualized basis producing an aver...
-Reuters
Premier Inc. to be acquired by Patient Square Capital at $28.25 per share, offering shareholders a 23.8% premium.
